EMYLEE BROWN: Open Payments
NPI 1619756210 · MOORESVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,084 in 105 payments from 28 companies in 2025. Trend: 2023 $194 · 2024 $1,666 · 2025 $2,084
Food & beverage: $2,084
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 10 | $279 |
| Novo Nordisk Inc | 11 | $239 |
| Lilly USA, LLC | 10 | $160 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 8 | $145 |
| IBSA Pharma Inc. | 7 | $140 |
| Amgen Inc. | 9 | $140 |
| SANOFI-AVENTIS U.S. LLC | 5 | $122 |
| Amneal Pharmaceuticals LLC | 5 | $95 |
| Ascendis Pharma Endocrinology Inc | 4 | $93 |
| Madrigal Pharmaceuticals | 4 | $84 |
Products named: TREMFYA, Rybelsus, JARDIANCE, XIFAXAN, Tirosint, TZIELD, TEPEZZA, UNITHROID.
Industry payments across NC — which companies pay providers there.
